07:00 , Jun 26, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Kinase inhibitor of nuclear factor-kB-1 (KINK-1); IkB kinase-b (IKKb); NF-kB Studies in cell lines and mice suggest that KINK-1...